# Anti-platelet Therapy in the Prevention of Cardiovascular Disease in Patients With COPD (APPLE-COPD: ICON 2)

> **NCT03487406** · PHASE2 · COMPLETED · sponsor: **Newcastle-upon-Tyne Hospitals NHS Trust** · enrollment: 120 (actual)

## Conditions studied

- Chronic Obstructive Pulmonary Disease (COPD)

## Interventions

- **DRUG:** Ticagrelor
- **DRUG:** Aspirin
- **DRUG:** Placebo Aspirin
- **DRUG:** Placebo Ticagrelor

## Key facts

- **NCT ID:** NCT03487406
- **Lead sponsor:** Newcastle-upon-Tyne Hospitals NHS Trust
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-09
- **Primary completion:** 2017-11
- **Final completion:** 2017-11
- **Target enrollment:** 120 (ACTUAL)
- **Last updated:** 2018-04-04

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03487406

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03487406, "Anti-platelet Therapy in the Prevention of Cardiovascular Disease in Patients With COPD (APPLE-COPD: ICON 2)". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03487406. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*